===================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
March 3, 2005
VisualMED Clinical Solutions Corp.
|
NEVADA |
000-33191 |
88-0436055 |
|
(State or other jurisdiction of incorporation) |
(Commission File No.) |
(IRS Employer ID) |
1035 Laurier Street West
Montreal, Quebec H2V 2L1
(Address of principal executive offices and Zip Code)
(514) 274-1115
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
[ ] |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
|
|
[ ] |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
|
|
[ ] |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
|
|
[ ] |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
===================================================================================
ITEM 7.01 REGULATION FD DISCLOSURE
VisualMED Clinical Solutions Corp. has signed a cooperation agreement with engineering firm SNC Lavalin of Montreal, Canada.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
|
(c) |
Exhibits |
||
|
|
|||
|
|
|
99.1 |
Press Release |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated this 3rd day of March, 2005.
|
|
VISUALMED CLINICAL SOLUTIONS CORP. |
|
|
|
|
|
|
BY: |
/s/ Barry Scharf |
|
|
|
|
Barry Scharf |
|
|
|
VP Operations |